Privacy & Cookies Policy
This website uses cookies to improve your experience. We'll assume
you're ok with this, but you can opt-out if you wish.Cookie settings
Impact of an Educational Program on Efficacy and Adherence with a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes, 34(2): 174-183.
This website uses cookies to improve your experience. We’ll assume you’re ok with this, but you can opt-out if you wish. [cookie_settings] [cookie_button]